JPMorgan Chase & Co’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $886K | Buy |
623,792
+125,071
| +25% | +$178K | ﹤0.01% | 3792 |
|
|
2025
Q1 | $763K | Buy |
498,721
+410,401
| +465% | +$628K | ﹤0.01% | 3801 |
|
|
2024
Q4 | $219K | Buy |
88,320
+79,844
| +942% | +$198K | ﹤0.01% | 4496 |
|
|
2024
Q3 | $9.75K | Sell |
8,476
-428
| -5% | -$492 | ﹤0.01% | 5323 |
|
|
2024
Q2 | $9.79K | Sell |
8,904
-60,764
| -87% | -$66.8K | ﹤0.01% | 5262 |
|
|
2024
Q1 | $86.4K | Buy |
69,668
+95
| +0.1% | +$118 | ﹤0.01% | 4795 |
|
|
2023
Q4 | $73.1K | Sell |
69,573
-330,748
| -83% | -$347K | ﹤0.01% | 4893 |
|
|
2023
Q3 | $2.74M | Sell |
400,321
-26,638
| -6% | -$182K | ﹤0.01% | 2808 |
|
|
2023
Q2 | $4.43M | Sell |
426,959
-2,208
| -0.5% | -$22.9K | ﹤0.01% | 2564 |
|
|
2023
Q1 | $3.47M | Buy |
429,167
+1,507
| +0.4% | +$12.2K | ﹤0.01% | 2683 |
|
|
2022
Q4 | $6.74M | Sell |
427,660
-25,305
| -6% | -$399K | ﹤0.01% | 2180 |
|
|
2022
Q3 | $7.13M | Sell |
452,965
-8,631
| -2% | -$136K | ﹤0.01% | 2093 |
|
|
2022
Q2 | $6.44M | Buy |
461,596
+416,946
| +934% | +$5.82M | ﹤0.01% | 2209 |
|
|
2022
Q1 | $770K | Buy |
44,650
+7,448
| +20% | +$128K | ﹤0.01% | 3767 |
|
|
2021
Q4 | $541K | Buy |
37,202
+7,376
| +25% | +$107K | ﹤0.01% | 4018 |
|
|
2021
Q3 | $536K | Buy |
29,826
+3,049
| +11% | +$54.8K | ﹤0.01% | 3916 |
|
|
2021
Q2 | $470K | Buy |
26,777
+26,756
| +127,410% | +$470K | ﹤0.01% | 4032 |
|
|
2021
Q1 | $1K | Sell |
21
-16
| -43% | -$762 | ﹤0.01% | 5179 |
|
|
2020
Q4 | $0 | Hold |
37
| – | – | ﹤0.01% | 4858 |
|
|
2020
Q3 | $0 | Hold |
37
| – | – | ﹤0.01% | 4762 |
|
|
2020
Q2 | $0 | Sell |
37
-179,044
| -100% | – | ﹤0.01% | 4699 |
|
|
2020
Q1 | $186K | Sell |
179,081
-26,387
| -13% | -$27.4K | ﹤0.01% | 3730 |
|
|
2019
Q4 | $388K | Sell |
205,468
-10,784
| -5% | -$20.4K | ﹤0.01% | 3542 |
|
|
2019
Q3 | $233K | Sell |
216,252
-192,010
| -47% | -$207K | ﹤0.01% | 3680 |
|
|
2019
Q2 | $870K | Buy |
408,262
+162,458
| +66% | +$346K | ﹤0.01% | 3125 |
|
|
2019
Q1 | $1.47M | Buy |
245,804
+51,660
| +27% | +$309K | ﹤0.01% | 2816 |
|
|
2018
Q4 | $1.44M | Buy |
194,144
+5,764
| +3% | +$42.6K | ﹤0.01% | 2840 |
|
|
2018
Q3 | $2.74M | Buy |
188,380
+4,351
| +2% | +$63.2K | ﹤0.01% | 2618 |
|
|
2018
Q2 | $3.68M | Sell |
184,029
-6,252
| -3% | -$125K | ﹤0.01% | 2441 |
|
|
2018
Q1 | $3.33M | Buy |
190,281
+185,266
| +3,694% | +$3.25M | ﹤0.01% | 2463 |
|
|
2017
Q4 | $124K | Buy |
+5,015
| New | +$124K | ﹤0.01% | 3826 |
|
|
2017
Q1 | – | Sell |
-7,620
| Closed | -$207K | – | 4409 |
|
|
2016
Q4 | $207K | Buy |
+7,620
| New | +$207K | ﹤0.01% | 3661 |
|